(Total Views: 615)
Posted On: 10/17/2021 1:12:50 PM
Post# of 72447
Thoughts on the recent oct 8k SEC filing:
On October 10, 2021, the Compensation Committee and Board of Directors of Innovation Pharmaceuticals Inc. (the “Company”) approved the following matters:
1. CEO Employment Agreement — The Compensation Committee approved, ……a new employment agreement for Leo Ehrlich, and staff …….Mr. Ehrlich’s previous agreement expired in January 2015
( Q:why a new EA now after a 6 year lapse.
A: IMO, major corporate growth events are imminent. )
2. In the new employment agreement continues Mr. Ehrlich’s current base salary of $475,000 per year
( Q: why no change here after 6 years?
A: IMO, he is extremely confident in the following to occur. )
3. The performance share awards Equity Incentive Plan, as amended maximum value of up to $35.0 million,
3a…which are contingent upon the achievement of certain market . capitalization, licensing revenue and,
3b…b]clinical trial performance goals[/b] and,
3c…cash awards with a maximum value of up to $14.0 million,
which are contingent upon the achievement of certain
market capitalization and licensing revenue goals.
Final IMO, the idea that he is planning on or hoping to be making 50mil means the we about to go one of the wildest stock rides of our lifetime.
As another poster keeps reminding us “ Know what you own” I second the motion. IPIX is a phenomenon with a seasoned leader in Mr Ehrlich.
On October 10, 2021, the Compensation Committee and Board of Directors of Innovation Pharmaceuticals Inc. (the “Company”) approved the following matters:
1. CEO Employment Agreement — The Compensation Committee approved, ……a new employment agreement for Leo Ehrlich, and staff …….Mr. Ehrlich’s previous agreement expired in January 2015
( Q:why a new EA now after a 6 year lapse.
A: IMO, major corporate growth events are imminent. )
2. In the new employment agreement continues Mr. Ehrlich’s current base salary of $475,000 per year
( Q: why no change here after 6 years?
A: IMO, he is extremely confident in the following to occur. )
3. The performance share awards Equity Incentive Plan, as amended maximum value of up to $35.0 million,
3a…which are contingent upon the achievement of certain market . capitalization, licensing revenue and,
3b…b]clinical trial performance goals[/b] and,
3c…cash awards with a maximum value of up to $14.0 million,
which are contingent upon the achievement of certain
market capitalization and licensing revenue goals.
Final IMO, the idea that he is planning on or hoping to be making 50mil means the we about to go one of the wildest stock rides of our lifetime.
As another poster keeps reminding us “ Know what you own” I second the motion. IPIX is a phenomenon with a seasoned leader in Mr Ehrlich.
(5)
(0)
Ronald A Phillips
